Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry

References

• Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–2121.
   PubMed Web of Science ®Google Scholar
• Liu Z, Davidson A. Taming lupus – a new understanding of pathogenesis is leading to clinical advances. Nat Med. 2012;18:871–882.
   PubMed Web of Science ®Google Scholar
• Simon JC. Lupus erythematosus: Part I: epidemiology, genetics and immunology. J Dtsch Dermatol Ges. 2013;28:709–718.
   Google Scholar
• Yee CS, Farewell VT, Isenberg DA, et al. The use of systemic lupus erythematosus disease activity index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology. 2011;50:982–988.
   PubMed Web of Science ®Google Scholar
• Ceccarelli F, Perricone C, Massaro L, et al. Assessment of disease activity in systemic lupus erythematosus: lights and shadows. Autoimmun Rev. 2015;14:601–608.
   PubMed Web of Science ®Google Scholar
• Thanou A, Merrill JT. Top 10 things to know about lupus activity measures. Curr Rheumatol Rep. 2013;15:1–7.
   Web of Science ®Google Scholar
• Gladman DD, Ilbanez D, Urovitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288–291.
   PubMed Web of Science ®Google Scholar
• Goldblatt F, O’Neill SG. Clinical aspects of autoimmune rheumatic diseases. Autoimmun Rheumatic Dis. 2013;382:398–808.
   Google Scholar
• Mosley K, Tam FEK, Edwards RJ, et al. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology. 2006;45:1497–1504.
   PubMed Web of Science ®Google Scholar
• Ahearn JM, Liu CC, Kao AH, et al. Biomarkers for systemic lupus erythematosus. Transl Res. 2012;159:326–342.
   PubMed Web of Science ®Google Scholar
• Knepper MA. Proteomics and the kidney. J Am Soc Nephrol. 2002;13:1398–1408.
   PubMed Web of Science ®Google Scholar
• Oates JC, Varghese S, Bland AM, et al. Prediction of urinary protein markers in lupus nephritis. Kidney Int. 2005;68:2588–2592.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Song H, Birmkngham DJ, et al. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol. 2005;16:467–473.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Birmkngham DJ, Nagaraja HN, et al. Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis. 2007;65:187–193.
   PubMedGoogle Scholar
• Varghese SA, Powell TB, Budisavljevic MN, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007;18:913–922.
   PubMed Web of Science ®Google Scholar
• Zhang X, Jin M, Wu H, et al. Biomarker discovery for lupus nephritis through longitudinal urine proteomics. Kidney Int. 2008;74:799–807.
   PubMed Web of Science ®Google Scholar
• Wu T, Mohan C. Proteomic toolbox for autoimmunity research. Autoimmun Rev. 2009;8:595–598.
   PubMed Web of Science ®Google Scholar
• Huang Z, Shi Y, Cai B, et al. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus. Rheumatology. 2009;48:626–631.
   PubMed Web of Science ®Google Scholar
• Somparn P, Hirankam N, Leelahavanichkul A, et al. Urinary proteomics revealed prostaglandin H2D-isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritis. J. Proteomics. 2012;75:3240–3247.
   PubMed Web of Science ®Google Scholar
• Rana A, Minz RW, Aggarwal R, et al. A comparative proteomic study of sera in pediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS – a pilot study. Pediatr Rheumatol. 2012;24:1–10.
   Google Scholar
• da Fonseca-Pires S, Fialho LC, Silva SO, et al. Identification of virulence factors in Leishmania infantum strains by a proteomic approach. J Proteome Res. 2014;13:1860–1872.
   PubMed Web of Science ®Google Scholar
• Neuroff V, Arnold N, Taube D, Ehrhardt W. Improved staining of protein in polyacrylamide gels including isoeletric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis. 1988;9:255–262.
   PubMed Web of Science ®Google Scholar
• Costa MM, Andrade HM, Bartolomeu DC, et al. Analysis of Leishmania chagasi by 2-D difference gel electrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine. J Proteome Res. 2011;10:2172–2184.
   PubMed Web of Science ®Google Scholar
• Smith-Bouvier DL, Divekar AA, Sasidhar M, et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med. 2008;205:1099–1108.
   PubMed Web of Science ®Google Scholar
• Pons-Estel GJ, Alarcon GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010;39:257–268.
   PubMed Web of Science ®Google Scholar
• Dai Y, Hu C, Huang Y, et al. A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 2008;17:799–804.
   PubMed Web of Science ®Google Scholar
• Saso L, Silvestrini IB, Guglielmotti A, et al. Glycosylation of alpha-2-macroglobulin, a non-acute-phase protein, in patients with autoimmune diseases. Inflammation. 1993;17:465–479.
   PubMed Web of Science ®Google Scholar
• Panzironi C, Silvestrini B, My MO, et al. An increase in the carbohydrate moiety of α2-macroglobulin is associated with systemic lupus erythematosus (SLE). Biochem Mol Biol Int. 1997;43:1305–1322.
   PubMedGoogle Scholar
• Cazzolla N, Saso L, Grima J, et al. Development of an enzyme-linked immunosorbent assay, using a monoclonal antibody against a2-macroglobulin, for the diagnosis of systemic lupus erythematosus. Clin Biochem. 1999;32:249–255.
   PubMed Web of Science ®Google Scholar
• Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus – an update. Curr Opin Immunol. 2012;24:651–657.
   PubMed Web of Science ®Google Scholar
• Choi-Miura NH, Takahashi Y, Nakano Y, et al. Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J). J Biochem. 1992;112:557–561.
   PubMed Web of Science ®Google Scholar
• Chau-Han AK, Moore TL. Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC). Clin Exp Immunol. 2006;145:398–406.
   PubMed Web of Science ®Google Scholar
• Blake CCF, Geisow MJ, Oatley SJ. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Angstroms. J Mol Biol. 1978;121:339–356.
   PubMed Web of Science ®Google Scholar
• Jiang X, Smith CS, Petrassi HM, et al. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry. 2001;40:11442–11452.
   PubMed Web of Science ®Google Scholar
• Kazemipour N, Qazizadeh H, Sepehrimanesh M, Salimi S. Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus. Lupus. 2015;24:582–587.
   PubMed Web of Science ®Google Scholar
• Sesso R, Rettori R, Nishida S, et al. Assessment of lupus nephritis activity using urinary retinol-binding protein. Nephrol Dial Transplant. 1994;9:367–371.
   PubMed Web of Science ®Google Scholar
• Marks SD, Shah V, Pilkington C, et al. Renal tubular dysfunction in children with systemic lupus erythematosus. Pediatr Nephrol. 2005;20:141–148.
   PubMed Web of Science ®Google Scholar
• Farjo KM, Farjo RA, Halsey S, et al. Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism. Mol Cell Biol. 2012;32:5103–5115.
   PubMed Web of Science ®Google Scholar
• Jialau J, Adams-Huet B, Duong F, Smith G. Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation. Metab Syndr Relat Disord. 2014;12:227–230.
   PubMed Web of Science ®Google Scholar
• Dorner T, Heimbacher C, Farner NL, Lispsky PE. Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus. Clin Immunol. 1999;92:188–196.
   PubMed Web of Science ®Google Scholar
• Fraser L, Coped D’Cruz AD, Spencer J. Immunoglobulin light chain allelic exclusion in systemic lupus erythematosus. Immunology. 2011;135:168.
   Web of Science ®Google Scholar
• Botvinovckaya AV, Kostrikina IA, Buneva VN, Nevisnky GA. Systemic lupus erythematosus: molecular cloning of several recombinant DNase monoclonal kappa light chains with different catalytic properties. J Mol Recogn. 2013;26:450–460.
   PubMed Web of Science ®Google Scholar
• Andrews SF, Zhang Q, Lim Q, et al. Global analysis of B cell selection using an immunoglobulin light chain-mediated model of autoreactivity. J Exp Med. 2014;210:125–142.
   Web of Science ®Google Scholar
• Fan Y, Murphy TB, Byrne JC, et al. Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer. J Proteome Res. 2011;10:1361–1373.
   PubMed Web of Science ®Google Scholar